RAPT Therapeutics, Inc. (RAPT) Marketable Securities, Current USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: RAPT Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from 2020 to 2024.
RAPT Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $96.3 M, a 48.2% decline year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$96.3 M	-$89.6 M	-48.2%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$111 M	-$98.7 M	-47%	Dec 31, 2023	10-Q	2024-05-09
Q3 2023	$131 M	-$37.1 M	-22.1%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$155 M	+$4.7 M	+3.13%	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$186 M	+$45.3 M	+32.2%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$210 M	+$44.5 M	+26.9%	Dec 31, 2022	10-K	2024-03-07
Q3 2022	$168 M	+$16.9 M	+11.2%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$150 M	+$13.1 M	+9.52%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$141 M	+$66.9 M	+90.8%	Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$166 M	+$79 M	+91.3%	Dec 31, 2021	10-K	2023-03-14
Q3 2021	$151 M	+$48.2 M	+47%	Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$137 M	+$33.1 M	+31.8%	Jun 30, 2021	10-Q	2021-08-11
Q1 2021	$73.7 M	+$27 M	+57.9%	Mar 31, 2021	10-Q	2021-05-11
Q4 2020	$86.6 M			Dec 31, 2020	10-K	2022-03-10
Q3 2020	$103 M			Sep 30, 2020	10-Q	2020-11-16
Q2 2020	$104 M			Jun 30, 2020	10-Q	2020-08-13
Q1 2020	$46.7 M			Mar 31, 2020	10-Q	2020-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.